Kakamigahara, Japan

Norishige Takami

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norishige Takami. Retrieved from https://idiyas.com/inventor/norishige-takami

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Norishige Takami - Innovator in Orally Rapid Disintegrating Tablet Preparations

Introduction

Norishige Takami is an inventor based in Kakamigahara-Shi, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of orally rapid disintegrating tablet preparations. His innovative approach focuses on enhancing the delivery of fat-soluble active ingredients.

Latest Patent Applications

Takami's notable patent application is titled "ORALLY RAPID DISINTEGRATING TABLET PREPARATION COMPRISING FAT-SOLUBLE ACTIVE INGREDIENTS." This invention provides a formulation that contains a high dose of a fat-soluble active ingredient, which exhibits excellent disintegration characteristics in the oral cavity. The preparation can be produced using a dry tabletting method. The invention also outlines a method for producing the orally rapid disintegrating tablet preparation. It discloses a formulation obtained by tabletting a uniform mixture of saccharide alcohol, crystalline cellulose, and a lubricant with a granule produced by the adsorption of a fat-soluble active ingredient on a porous material.

Conclusion

Norishige Takami's work in the field of orally rapid disintegrating tablets showcases his innovative spirit and dedication to improving pharmaceutical formulations. His contributions have the potential to enhance the effectiveness of drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…